Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Margaret L Musser"'
Publikováno v:
PLoS ONE, Vol 17, Iss 12, p e0279594 (2022)
Canine splenic hemangiosarcoma (HSA) is an aggressive tumor with a short overall survival time (OST) despite treatment with splenectomy and adjuvant doxorubicin. Modulation of the immune system has been shown to be effective for a variety of human tu
Externí odkaz:
https://doaj.org/article/b298880c86734102b2054718e869cb43
Publikováno v:
Journal of Veterinary Internal Medicine, Vol 38, Iss 6, Pp 3162-3169 (2024)
Abstract Background Information regarding response rate to tigilanol tiglate for mast cell tumors in dogs is limited. Objectives Report the response rate and durability of tigilanol tiglate intratumoral treatment in dogs with mast cell tumors present
Externí odkaz:
https://doaj.org/article/41a3474d48f841478cefbe13b6b24675
Autor:
Haylie C. Lawson, Margaret L. Musser, Rebecca Regan, Antony S. Moore, Ann Hohenhaus, Brian Flesner, Chad M. Johannes
Publikováno v:
Journal of Veterinary Internal Medicine, Vol 36, Iss 1, Pp 234-243 (2022)
Abstract Background Despite multiple reports of chemotherapy overdoses (ODs) in human and veterinary medicine, anthracycline ODs have been described infrequently. Hypothesis/Objectives Describe toxicities, treatments, and overall outcome after anthra
Externí odkaz:
https://doaj.org/article/8b76ae9edcf14761854fcfd3b1510512
Autor:
Margaret L. Musser, Chad M. Johannes
Publikováno v:
BMC Veterinary Research, Vol 17, Iss 1, Pp 1-6 (2021)
Abstract Background Canine pancreatic carcinoma is a rare, aggressive tumour that is often diagnosed late in the course of disease. Effective treatment strategies have been elusive, and overall survival time is short. In humans, treatment with tyrosi
Externí odkaz:
https://doaj.org/article/3303802635e54582aeffd92172561d08
Autor:
Margaret L. Musser, Austin K. Viall, Rachel L. Phillips, Jesse M. Hostetter, Chad M. Johannes
Publikováno v:
BMC Veterinary Research, Vol 16, Iss 1, Pp 1-10 (2020)
Abstract Background Chronic inflammation mediated by the cyclooxygenase enzymes, specifically their product prostaglandin E2 (PGE2), can result in the development of cancer. PGE2 promotes cell proliferation, apoptosis, and angiogenesis through intera
Externí odkaz:
https://doaj.org/article/e171a6fad89d4f7fb6289a9adf1dd8f8
Publikováno v:
Frontiers in Veterinary Science, Vol 8 (2021)
Chemotherapy overdoses (ODs) are severe complications that can occur following the use of antineoplastics. However, little is known about chemotherapy ODs in veterinary medicine. The goals of this retrospective study were to report the occurrence, ty
Externí odkaz:
https://doaj.org/article/b15806da56934e10a29218641e2e4d9a
Publikováno v:
BMC Veterinary Research, Vol 15, Iss 1, Pp 1-4 (2019)
Abstract Background Listeria monocytogenes is a promising therapeutic vaccine vector for cancer immunotherapy. Although highly attenuated, three cases of systemic listeriosis have been reported in people following treatment with Listeria-based therap
Externí odkaz:
https://doaj.org/article/c58d53ec9af4495f9a71fa9a0a34b3ab
Autor:
Giovanna M. Coto, Margaret L. Musser, Melissa A. Tropf, Jessica L. Ward, Yeon-Jung Seo, Jonathan P. Mochel, Chad M. Johannes
Publikováno v:
Frontiers in Veterinary Science, Vol 8 (2021)
Aortic body tumors, specifically chemodectomas, are the second most common type of canine cardiac tumor; however, information about treatment is currently lacking. This study included dogs with a presumptive or definitive diagnosis of an aortic body
Externí odkaz:
https://doaj.org/article/9ac8389baa9242f9b354c12a6097000d
Publikováno v:
BMC Veterinary Research, Vol 14, Iss 1, Pp 1-7 (2018)
Abstract Background Effective treatment options for inoperable, metastatic, or recurrent canine pheochromocytomas are lacking. In humans, specific germline mutations exist that drive the development of pheochromocytomas. Pharmaceutical blockade of th
Externí odkaz:
https://doaj.org/article/c0a553d869534b02a1c3ff791b53e78a
Autor:
Margaret L. Musser, Alyssa L. Mahaffey, Melissa A. Fath, Garry R. Buettner, Brett A. Wagner, Benjamin K. Schneider, Yeon-Jung Seo, Jonathan P. Mochel, Chad M. Johannes
Publikováno v:
Frontiers in Veterinary Science, Vol 6 (2019)
Background: High-dose, pharmacological ascorbate (P-AscH−) is preferentially cytotoxic to human cancer cells in vitro. Investigations on the efficacy of P-AscH− as an adjuvant treatment for multiple human cancers are on-going, but has yet to be f
Externí odkaz:
https://doaj.org/article/b8897e984f134104ace17fbd27f676f2